• Hero Banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Buying or Selling a Practice
Hospital Design
Leadership & Personal Growth
Personnel Management
Practice Finances
Practice Operations
Technology
Wellbeing & Lifestyle
Continuing Education
Conferences
Live Conferences
Conference News
Conference Proceedings
Resources
CBD in Pets
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Fleas Likely Not Resistant to New Flea Control Products

April 11, 2016
Laurie Anne Walden, DVM, ELS

Product failures with new topical and oral flea treatments are probably caused by failure to use the products correctly rather than product resistance, according to a recent review article.

Product failures with new topical and oral flea treatments are probably caused by failure to use the products correctly rather than product resistance, according to a review recently published in Insects.

Ctenocephalides felis (the most common flea species) has been shown to have resistance to carbamates, pyrethroids, pyrethrins, organochlorine, and organophosphates, writes Dr. Michael K. Rust, of the University of California Riverside. However, resistance to newer oral and topical flea control products has not been demonstrated.

Advertisement

The number of flea products on the market has increased in the past several years. “Unlike many situations in agricultural pest management, [the increase in new products] is not in response to a failure of new products to control fleas or the development of insecticide resistance,” writes Dr. Rust. “Rather, it is due to the lucrative nature of the flea control market and to the consumer’s desire for extra convenience.”

Lufenuron, fipronil, and imidacloprid became available in the 1990s, and C. felis has not developed significant resistance to these compounds over the years. These compounds, as well as fluralaner, pyriproxyfen, and selamectin, disrupt the flea life cycle by killing fleas before they feed and lay eggs. In this way they may avoid the problem of resistance.

Although insecticide resistance is sometimes the blame for product failures, operational factors are often the true culprits and wild animals also harbor fleas that can re-infest pets. Reported causes of product failure in treated pets include the following:

  • Failure to properly apply the product
  • Failure to follow label instructions
  • Failure to treat all household pets
  • Failure to apply the product all year round
  • Excessive bathing, which may alter the efficacy of some topical products

Investigating insecticide resistance in fleas is complicated by the lack of a standard susceptible flea strain to use in laboratory studies. Many laboratory strains of fleas have genetic mutations linked to pyrethroid resistance. Field populations of fleas should also be monitored to assess their response to new insecticides. “Vigilance is necessary if we are to protect and preserve our active chemistries for flea control,” says Dr. Rust.

Dr. Laurie Anne Walden received her doctorate in veterinary medicine from North Carolina State University in 1994. After an internship at Auburn University College of Veterinary Medicine, she returned to North Carolina, where she has been in companion animal general practice for over 20 years. Dr. Walden is also a board-certified Editor in the Life Sciences and owner of Walden Medical Writing.

Related Content:

Parasitology
Preventing transmission of Lyme disease
Preventing transmission of Lyme disease
Podcast CE: 360 parasite protection
Podcast CE: 360 parasite protection
New broad-spectrum parasite protection for cats receives FDA approval
New broad-spectrum parasite protection for cats receives FDA approval

Advertisement

Latest News

Locoregional analgesia for pain management in veterinary medicine

Outside toxicology experts can save pets’ lives

Lyon College School of Veterinary Medicine names founding dean

Morris Animal Foundation funds study on environmental toxins and lymphoma

View More Latest News
Advertisement